Mustang Bio (MBIO) News Today $0.18 -0.01 (-5.35%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Mustang Bio Interim CFO James Murphy ResignsNovember 16, 2024 | markets.businessinsider.comMustang Bio's Interim CFO Resigns After 10 MonthsNovember 15, 2024 | marketwatch.comMustang Bio Faces Nasdaq Delisting and Leadership ChangesNovember 15, 2024 | markets.businessinsider.comMustang Bio, Inc.: Mustang Bio Receives Positive Listing Determination from NasdaqNovember 12, 2024 | finanznachrichten.deMustang Bio Receives Positive Listing Determination from NasdaqNovember 12, 2024 | globenewswire.comMustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant GliomaNovember 7, 2024 | globenewswire.comMustang Bio Secures $4M through Strategic Warrant AgreementOctober 26, 2024 | markets.businessinsider.comMustang Bio Announces Exercise of Warrants for $4 Million Gross ProceedsOctober 24, 2024 | globenewswire.comMustang Bio treatment of malignant glioma granted FDA orphan statusOctober 23, 2024 | markets.businessinsider.comMustang Bio (NASDAQ:MBIO) Stock, Short Interest ReportSeptember 28, 2024 | benzinga.comMustang Bio (NASDAQ:MBIO) Stock Quotes, Forecast and News SummarySeptember 28, 2024 | benzinga.comSangamo Therapeutics, Inc. (GBY.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comDiamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)June 28, 2024 | globenewswire.comMustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesJune 21, 2024 | globenewswire.comMustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesJune 20, 2024 | globenewswire.comCrude Oil Rises 1%; Mustang Bio Shares Spike HigherJune 17, 2024 | benzinga.comWhy Is Mustang Bio (MBIO) Stock Up 347% Today?June 17, 2024 | investorplace.comMustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T TherapyJune 17, 2024 | globenewswire.comWhy Is Mustang Bio (MBIO) Stock Up 58% Today?May 22, 2024 | investorplace.comWhy Is Mustang Bio (MBIO) Stock Up 58% Today?May 22, 2024 | investorplace.comMBIO Stock Earnings: Mustang Bio Beats EPS for Q1 2024May 16, 2024 | investorplace.comMustang Bio Earns Buy Rating: Strong Financials and Promising Clinical DevelopmentsMay 13, 2024 | markets.businessinsider.comMustang Bio Announces Closing of $4 Million Public OfferingMay 2, 2024 | globenewswire.comLSD Microdosing For PMS? After Confirming Antidepressant Effects, Clinical Trials Will Assess If It Addresses Mood IssuesApril 30, 2024 | msn.comMustang Bio Announces Pricing of $4 Million Public OfferingApril 29, 2024 | globenewswire.comWorcester biotech down to 11 employees after asset sale stallsApril 22, 2024 | bizjournals.comBiotech cites federal review of deal with Chinese firm in latest staff cutsApril 16, 2024 | bizjournals.comMustang Bio stock tumbles 27% amid news of mass layoffsApril 15, 2024 | msn.comMustang Bio announces major workforce reductionApril 14, 2024 | investing.comMustang Bio to Cut Global Headcount by 81%April 12, 2024 | marketwatch.comMustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune DiseasesMarch 28, 2024 | globenewswire.comMustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsMarch 11, 2024 | globenewswire.comMustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Ra2-targeted CAR T-Cells in High-Grade GliomaMarch 7, 2024 | tmcnet.comWhy Rush Street Interactive Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving PremarketMarch 7, 2024 | markets.businessinsider.comMustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade GliomaMarch 7, 2024 | globenewswire.comMustang Bio Inc (MBIO)February 13, 2024 | uk.investing.comMustang Bio to Participate in the B. Riley Securities 4th Annual Oncology ConferenceJanuary 11, 2024 | finance.yahoo.comMustang Bio Inc MBIOJanuary 6, 2024 | morningstar.comMustang Bio Stock (NASDAQ:MBIO) Dividends: History, Yield and DatesDecember 27, 2023 | benzinga.comMBIO Mustang Bio, Inc.December 22, 2023 | seekingalpha.comMustang Bio files to sell 2.74M shares of common stock for holdersDecember 12, 2023 | msn.comMustang Bio’s Positive Financial Performance and Promising Clinical Developments Drive Buy RatingNovember 15, 2023 | markets.businessinsider.comMustang Bio, Inc.: Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNovember 15, 2023 | finanznachrichten.deMustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation at 65th American Society of Hematology (ASH) Annual MeetingNovember 2, 2023 | finance.yahoo.comMustang Bio Announces Closing of $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesOctober 30, 2023 | finance.yahoo.comMustang Bio Shares Rise 13% After FDA Acceptance of IND ApplicationOctober 26, 2023 | marketwatch.comMustang Bio Announces FDA Acceptance of IND Application for MB-109, a Novel Combination of MB-101 (IL13Rα2‐targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus), for the Treatment of Recurrent Glioblastoma and High-Grade AstrocytomaOctober 26, 2023 | finance.yahoo.comCantor Fitzgerald Reiterates Mustang Bio (MBIO) Overweight RecommendationAugust 25, 2023 | nasdaq.comMustang Bio, Inc.: Mustang Bio Reports Second Quarter 2023 Financial Results and Recent Corporate HighlightsAugust 15, 2023 | finanznachrichten.deWhat 4 Analyst Ratings Have To Say About Mustang BioAugust 15, 2023 | markets.businessinsider.com Get Mustang Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for MBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address This drone stock is setting up to transform medical supply delivery (Ad)Drone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks. Click here to see how a new partnership could catapult this drone suppliers' growth MBIO Media Mentions By Week MBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MBIO News Sentiment▼1.870.65▲Average Medical News Sentiment MBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MBIO Articles This Week▼00▲MBIO Articles Average Week Get Mustang Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for MBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OKYO News AFMD News ANEB News VRCA News OTLK News SRZN News IXHL News RAPT News RNXT News PMN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MBIO) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mustang Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mustang Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MBIO Stock Alerts